Trial intelligence / Profile preview

Near-infrared ICG imaging to locate pulmonary metastases

jRCTs051180044Completed

Start
Jan 2019
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of indocyanine green in cancer. Primary endpoints: Safety of intravenous indocyanine green and Intraoperative fluorescence detection of pulmonary metastases. Started Jan 2019; status: completed.

02

Drugs

indocyanine green
03

Conditions

cancer

Beyond the preview

Go deeper on jRCTs051180044.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs051180044.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call